BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OptikNow - ECPv6.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OptikNow
X-ORIGINAL-URL:https://www.optiknow.ca
X-WR-CALDESC:Events for OptikNow
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220922T150000
DTEND;TZID=America/Toronto:20220922T161500
DTSTAMP:20260602T081353
CREATED:20220809T203856Z
LAST-MODIFIED:20220809T203856Z
UID:97163-1663858800-1663863300@www.optiknow.ca
SUMMARY:Gene Agnostic Therapies
DESCRIPTION:Over the past few years we have talked a lot about the promise of gene therapy – treatments designed for a specific gene\, like Luxturna for RPE56. There is growing interest now in therapies that are not designed for a specific gene – but instead may be able to treat many mutations causing at disease. These potential treatments are called gene agnostic therapies. \nIn this webinar\, join us for a conversation with Dr. Daniel Chung\, chief medical officer at SparingVision\, which is developing a gene-agnostic therapy to preserve cone vision in people with retinitis pigmentosa\, Usher syndrome\, and related conditions.
URL:https://www.optiknow.ca/event/gene-agnostic-therapies/
LOCATION:Virtual
CATEGORIES:Virtual Event
ATTACH;FMTTYPE=image/png:https://www.optiknow.ca/wp-content/uploads/2022/08/hey.png
END:VEVENT
END:VCALENDAR